Metropolis Healthcare Ltd Financials
Company Logo

Metropolis Healthcare Ltd Financial Statement

Metropolis Healthcare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue288.96
Operating Expense217.87
Net Profit31.28
Net Profit Margin10.83
Earning Per Share6.11
EBIDTA71.50
Effective Tax Rate15.26

Metropolis Healthcare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual1,103.43
Operating Expenses Annual844.94
Operating Profit Annual270.48
Interest Annual22.34
Depreciation75.50
Net Profit Annual115.89
Tax Annual41.52

Metropolis Healthcare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning24.09
Cash Flow from Operations269.01
Cash Flow from Investing-81.51
Cash Flow from Financing-183
Cash Flow at the End28.59

Metropolis Healthcare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)24.96
PBIT Margin (%)16.74
PBT Margin (%)16.13
Net PROFIT Margin (%)10.50
Return On Networth / Equity (%)11.78
Return On Networth /Employed (%)15.02
Return On Assets (%)9.45
Total Debt / Equity (X)0.24
Asset Turnover Ratio (%)0.90

Metropolis Healthcare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual1,120.09
Total Current Assets Annual272.44
Non Current Assets Annual1,200.26
Total Shareholders Funds Annual1,031.19
Total Assets Annual1,472.70

Metropolis Healthcare Ltd Earning Calls

EPS (INR)

Expected

7.40

Reported

7.41

Surprise

0.14%

Mar 2024

EPS beaten by 0.14%

Dec 2023

EPS beaten by 0.14%

Sep 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 5, 2024, Metropolis Healthcare Ltd has a market capitalization of 8,843.81 Cr. Value Research classifies it as a Mid-Cap company.
Yes, Metropolis Healthcare Ltd is debt-free with a debt-to-equity ratio of 0.19.
In FY 2023 , Metropolis Healthcare Ltd recorded a total revenue of approximately 1,103.43 Cr marking a significant milestone in the company's financial performance.
Metropolis Healthcare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and -0.0% annually, respectively..
Metropolis Healthcare Ltd's current PE ratio is 76.31.
Metropolis Healthcare Ltd's ROCE averaged 18.6% from the FY ending March 2022 to 2024, with a median of 17.1%. It peaked at 23.9% in March 2022, reflecting strong capital efficiency over the period..
Metropolis Healthcare Ltd's latest EBIT is Rs. 179.75 Cr, surpassing the average EBIT of Rs. 225.51 Cr over the 5 years..